← Back to charts
Lung Nodule Follow-up Guide icon
APP STORE

Lung Nodule Follow-up Guide

RADIOLOGiQ, LLC · Medical · United States store
NOT IN TOP 100 HERE
View on App Store ↗ Instagram card Google Play version →
Revenue a month, worldwide EST
$301
Likely $100 to $902
▼ 99.0% in 16 days
New ratings
+0
in 4 days, 87 in total
Rating
4.6 of 5
36 ratings in this store
Countries it ranks in
1
was 2 on Oct 19, 2026

Revenue

Estimated from the grossing charts of Oct 26, 2026 in the 53 countries we track, and ratings growth on the App Store.

EST. REVENUE / YEAR · WORLDWIDE
$3.6K
0.5 new ratings a month on average since launch
EST. LIFETIME DOWNLOADS
1.3K to 3.6K
Estimated from ratings count
WHERE ITS USERS ARE · SHARE OF RATINGS
  • United States 36 ratings41%
  • Brazil 15 ratings17%
  • Italy 10 ratings11%
  • France 7 ratings8%
  • Australia 5 ratings6%
  • Canada 4 ratings5%
  • United Kingdom 2 ratings2%
  • Germany 2 ratings2%
HOW SURE ARE WE
Not in any grossing chart, so this comes from ratings growth (0.5 new ratings a month on average since launch): revenue grows with new ratings, more slowly for apps that collect ratings fast. Tested on 418 apps with verified revenue: typically off by about 2 times, and big earners tend to come out low. Countries we don't track (and Google Play in China, which doesn't exist) aren't included, and neither are ads or web payments. Gross revenue before store fees.
RATINGS
36
AVG RATING
4.61
PRICE
Free
AGE
14.4y
LAST UPDATE
329d ago
VERSION
8.2
SIZE
62 MB
AGE RATING
12+

Last 30 days

From our daily snapshots of every grossing chart and daily ratings counts.

DAYS IN A GROSSING CHART
21 / 30
COUNTRIES NOW
1 (was 2)
NEW RATINGS, LAST 4 DAYS
+0
EST. REVENUE A MONTH, DAILY · BOTH STORES EST
Show daily values
Sep 27, 2026not in a grossing chart
Sep 28, 2026not in a grossing chart
Sep 29, 2026not in a grossing chart
Sep 30, 2026not in a grossing chart
Oct 1, 2026$7.1K a month
Oct 2, 2026$10.2K a month
Oct 3, 2026$8.8K a month
Oct 4, 2026not in a grossing chart
Oct 5, 2026not in a grossing chart
Oct 6, 2026not in a grossing chart
Oct 7, 2026not in a grossing chart
Oct 8, 2026not in a grossing chart
Oct 9, 2026not in a grossing chart
Oct 10, 2026$30.2K a month
Oct 11, 2026not in a grossing chart
Oct 12, 2026not in a grossing chart
Oct 13, 2026not in a grossing chart
Oct 14, 2026not in a grossing chart
Oct 15, 2026not in a grossing chart
Oct 16, 2026not in a grossing chart
Oct 17, 2026not in a grossing chart
Oct 18, 2026not in a grossing chart
Oct 19, 2026not in a grossing chart
Oct 20, 2026$6K a month
Oct 21, 2026not in a grossing chart
Oct 22, 2026not in a grossing chart
Oct 23, 2026$1.1K a month
Oct 24, 2026not in a grossing chart
Oct 25, 2026$1K a month
Oct 26, 2026$301 a month
The same estimate as the headline, saved every day. Best rank Sep 27, 2026: #86 Medical · ES. Now: #72 Medical · IT.
RATINGS IN THE CORE COUNTRIES, DAILY
Show daily values
Oct 22, 202687 ratings
Oct 23, 202687 ratings
Oct 24, 202687 ratings
Oct 25, 202687 ratings
Oct 26, 202687 ratings
87 on Oct 22, 2026, 87 on Oct 26, 2026. New ratings track new downloads, even outside the charts.

Money and momentum

Measured from the store, not estimated.

WHAT IT CHARGES
2 purchases listed
  • 12-Month Subscription$19.99
  • 6-Month Subscription$14.99
Top in-app purchases as listed on the App Store, in local prices.
REVIEW MOMENTUM
0.0 reviews / week
  • Recent reviews average4.2 stars
  • Recent 1 and 2 star share18%
From the latest 11 written reviews, covering 5269 days.
RELEASE CADENCE
0 updates in 90 days
  • Typical gap between releases89 days
From the last 25 versions listed on the App Store.
RATING BREAKDOWN
36 ratings
5★89%
4★0%
3★3%
2★0%
1★8%

What users want

From the latest 11 reviews on the United States App Store, May 23, 2012 to Jun 26, 2025: 18% are 1 or 2 stars. Open a theme to read what people wrote.

WHAT THEY COMPLAIN ABOUT · SHARE OF BAD REVIEWS

Only 2 of the latest 11 reviews are 1 or 2 stars, too few to find patterns. Users are mostly happy.

WHAT THEY ASK FOR

No feature requests in the latest reviews.

WORDS THAT KEEP COMING UP IN BAD REVIEWS

Nothing stands out.

WHAT THEY LOVE · SHARE OF GOOD REVIEWS
Useful, it helps25%

2 of the 4 and 5 star reviews.

★★★★★ Easy to use and understand. Thanks!
★★★★★ This app really is helpful for me to make recommendations for my referral patients.

Found by matching words and phrases in the reviews, not read by a person. A review can count toward more than one theme.

What users say

Latest reviews, United States App Store.

★★★★★Jun 26, 2025
Make it free

We loved the free old one !

★★★★★Aug 23, 2023
Needs update

There was an update in 2022. App is is still using the 2014, v1.1 edition.

★★★★★Aug 23, 2021
Great app

Sabes so much time and effort. My teacher showed me this app and now I just love it.

★★★★★Jun 6, 2019
Helpful information

Easy to use and understand. Thanks!

★★★★★Nov 2, 2016
Great app with clear figures

Thanks for the effort. It is very convenient.

★★★★★Jun 23, 2016
Recommended

This app is recommended by my Radiology department chairman for compliance with PQRS

Apps like this

Same category, earning about as much.

Store screenshots

ScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshot

App Store ads

Apple Search Ads this app ran in the last 90 days, from Apple's public ad repository.

Apple's ad repository couldn't be reached right now. Try again later.

Growth research

Where this app is buying and earning its users. Each link opens pre filtered.

ASO keywords

Most repeated terms in the listing. Highlighted ones also appear in the title.

lung11lung rads10nodule8rads6acr5acr lung5self assessment5modifier4solid4lung nodule3nodule follow3follow guide3lung nodules3fleischner society3rads v20223clinically significant3incidental findings3assessment question3question packs3month available3available price3price displayed3displayed vary3vary region3

What's new in 8.2

Version 8.2 • Added new self-Assessment quiz pack Version 8.1.2 • UI/UX refinements (optimized for iOS 26) Version 8.1.1 • General improvements (e.g. enhanced support for smaller devices) Version 8.1 • Added Brock (full model) calculator • Added FAQ section What's New in Version 8.0 v8.0 is our first major update in six years, bringing Lung Nodule Follow-up Guide up to Lung-RADS v2022 standards. To support ongoing maintenance, regular guideline updates, and self-assessment question packs, this release introduces a free trial—after which continued use requires a 6- or 12-month auto-renewing plan. Guideline Upgrades • Upgraded from ACR Lung-RADS v1.1 to ACR Lung-RADS v2022, ensuring you have the latest criteria for lung cancer screening. Added ‘S’ modifier integration for clinically significant incidental findings—instantly flag and address other notable abnormalities. Smarter Decision Support • Expert‑curated self‑assessment question packs. Complete rebuild • Re‑engineered from the ground up for smoother interaction and greater reliability. Brand‑new modern interface optimized for both iPhone and iPad. Full Dark Mode and Dynamic Type support for comfortable viewing in any environment. Pricing update • After the free trial, continued use requires a 6‑ or 12‑month auto‑renewing subscription. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions. Thanks for using Lung Nodule Follow-up Guide! Tap Settings ▸ Share Your Feedback to let us know how we can keep improving. Download includes a free trial; continued use requires a 6- or 12-month auto-renewing subscription.

Released May 22, 2012. Current version shipped Dec 1, 2025.

Store description

Download includes a free trial; continued use requires a 6‑ or 12‑month auto‑renewing subscription. Lung Nodule Follow-up Guide is a clinical decision-support guide that streamlines the evaluation and management of lung nodules discovered incidentally or through screening. Built on the Fleischner Society Guidelines 2017 and ACR Lung-RADS v2022, including the latest "S" modifier for clinically significant incidental findings, the app provides clear, step-by-step guidance at the point of care. Whether you're in radiology, pulmonology, or primary care, Lung Nodule Follow-up Guide helps you apply standardized recommendations with clarity and consistency. --- Key Features (unlocked after the free trial with an active subscription) Fleischner Society Guideliens 2017 Integration • Structured recommendations for both solid and sub-solid (non-solid and part-solid) nodules—based on nodule size, nodule attenuation, whether solitary or multiple, and patient-specific risk factors. ACR Lung‑RADS v2022 Integration • Full, in‑app access to every Lung‑RADS category (0–4X) plus the “S” modifier, with concise management instructions drawn directly from the guidelines. Dynamic Lung‑RADS Card • A single, color‑coded card that updates your Lung‑RADS score in real time as you enter screening round, nodule morphology, size, and growth—making classification fast. S Modifier Integration • Toggle clinically significant findings across organ systems (e.g., coronary calcium, thyroid nodule, liver lesion) and instantly receive tailored, ACR‑based follow‑up recommendations sourced from the ACR Incidental Findings White Papers. Common Issues Insights • Provides literature-backed guidance on frequently encountered challenges in managing lung nodules—whether incidental or identified through lung cancer screening. Covers key topics such as accurate nodule measurement, interpretation of modifiers, and stepwise management strategies, helping clinicians apply guidelines with precision and consistency. Self-Assessment Mode • Expert-curated self-assessment question packs. Brock (Full Model) Calculator • Calculate a CT-detected nodule’s 2–4 year malignancy risk. Enhanced Readability • Dark‑mode support, dynamic text sizing, and a distraction‑free interface optimized for hectic reading environments. Offline Access • All guideline logic run on‑device—no login or server needed. Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions. SUBSCRIPTION OPTIONS ¹ • 6‑Month subscription (free trial available) | Price displayed in‑app; may vary by region • 12‑Month subscription (free trial available) | Price displayed in‑app; may vary by region We strive to incorporate any updates to ACR Lung‑RADS or S Modifier guidance within 30 days of publication and plan to add new self‑assessment question packs every six months. Future feature additions and update frequency may change without notice. ¹ Payment & Renewal – Payment is charged to your Apple ID at confirmation. Subscriptions renew automatically unless auto-renew is turned off at least 24 hours before the end of the current period. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions. Note: If you switch plans or re-subscribe during the free trial, the remaining trial time is lost and you will be charged immediately. Privacy Policy: https://radiologiq.squarespace.com/privacy Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

See this store page in another country

Prices, ranks and reviews are per country. Revenue above is already worldwide.

More from RADIOLOGiQ, LLC

Medical Devices on Chest X-Ray
Medical
69 ratingsAnalyze →
Differential Diagnosis Guide
Medical
23 ratingsAnalyze →
Thoracic Lymph Node Map
Medical
25 ratingsAnalyze →
GFR Calculator (MDRD & CKD)
Medical
11 ratingsAnalyze →
Incidentaloma CT / MRI Guide
Medical
29 ratingsAnalyze →
Lung Cancer Screening Guide
Medical
17 ratingsAnalyze →
Lung CT Field Guide
Medical
11 ratingsAnalyze →
Cardiac Imaging Planes 1-2-3
Medical
6 ratingsAnalyze →
Clinical Imaging Calculator
Medical
3 ratingsAnalyze →